Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Morton Grove › NPI 1730194192
Physician

Vernovsky, Natalya

Vernovsky, Natalya was paid $39K by Medicaid between May 2022 and Dec 2023, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.

33Billing provider infoVERNOVSKY, NATALYA
MORTON GROVE, IL 60053
33aNPI1730194192assigned 07/31/2006
33bProvider typePediatrics Physician
28Total paid$39K
24GClaims681
24DCodes billed7
24AFirst – last monthMay 2022 – Dec 2023
Compared with peers

Next to other Pediatrics Physician providers in Illinois

Rank by total paid#991 of 1,805
Median peer was paid$55K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022414$25K
2023267$14K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 55% 453 442 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 29% 81 76 $11K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 7.0% 60 59 $3K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6.6% 35 31 $3K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.6% 13 13 $628.18
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 20 14 $290.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 19 14 $2.25

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.